Leveraging genomic deep learning models for non-coding variant effect prediction
The majority of genetic variants identified in genome-wide association studies of complex traits are non-coding, and characterizing their function remains an important challenge in human genetics. Genomic deep learning models have emerged as a promising approach to enable in silico prediction of variant effects. These include supervised sequence-to-activity models, which predict genome-wide chromatin states or gene expression levels directly from DNA sequence, and self-supervised genomic language models. Here, we review progress in leveraging these models for non-coding variant effect prediction. We describe practical considerations for making such predictions and categorize the types of ground truth data that have been used to evaluate deep learning-based variant effect predictions, providing insight into the settings in which current models are most useful. We also discuss downstream applications of such models to understanding disease-relevant non-coding variants. Our review highlights key considerations for practitioners and opportunities for future improvements in model development and evaluation.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
How chromatin interactions shed light on interpreting non-coding genomic variants: opportunities and future direc-tions
Genomic variants, including copy number variants (CNVs) and genome-wide associa-tion study (GWAS) single nucleotide polymorphisms (SNPs), represent structural alterations that influence genomic diversity and disease susc…
DYNA: Disease-Specific Language Model for Variant Pathogenicity
Clinical variant classification of pathogenic versus benign genetic variants remains a challenge in clinical genetics. Recently, the proposition of genomic foundation models has improved the generic variant effect predic…
Language ModelingLanguage ModellingmodelSpecificityThe Impact of Genomic Variation on Function (IGVF) Consortium
Our genomes influence nearly every aspect of human biology from molecular and cellular functions to phenotypes in health and disease. Human genetics studies have now associated hundreds of thousands of differences in our…
BenchmarkingSafeGenes: Evaluating the Adversarial Robustness of Genomic Foundation Models
Genomic Foundation Models (GFMs), such as Evolutionary Scale Modeling (ESM), have demonstrated significant success in variant effect prediction. However, their adversarial robustness remains largely unexplored. To addres…
Adversarial RobustnessDeep Learning in Pharmacogenomics: From Gene Regulation to Patient Stratification
This Perspective provides examples of current and future applications of deep learning in pharmacogenomics, including: (1) identification of novel regulatory variants located in noncoding domains and their function as ap…
Deep Learning